
Panelists challenge the belief that testosterone fuels prostate cancer, explain PSA on therapy and TRAVERSE BPH data, and weigh Schedule III status.
Chicago-Although laparoscopic nephron-sparing surgery is a firmly established procedure, its full potential has not yet been reached, according to a host of studies intended to demonstrate the expanding range of the procedure's applications.





